Laser eye pressure treatment for Black patients with open angle glaucoma

This trial is testing Direct Selective Laser Trabeculoplasty (DSLT), a laser procedure designed to lower eye pressure in patients with open angle glaucoma. The study focuses specifically on Black patients of African descent to understand how well this treatment works for this population. Researchers want to see if the laser treatment can reduce eye pressure by at least 20% and help some patients avoid or reduce the need for daily eye drop medications.

Open angle glaucoma is a serious eye condition that can lead to blindness if eye pressure is not controlled. While this laser treatment has been used in other patient populations, there is limited research on how well and safely it works for Black patients, so this study aims to fill that gap and ensure all patients have access to effective treatment options.